MedTrace Logo

Safety & Tolerability of Hypertonic Saline Administration Via Intraosseous Access

NCT03276494 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2019-07-09

Study results available
· View outcomes & findings →

Summary

Hypertonic saline is used to treat elevated intracranial pressure. Intraosseous vascular access has been used to administer fluids and medications. This study combines these to administer 3% hypertonic saline via IO.

Conditions

  • Stroke
  • Intracranial Hypotension
  • Cerebral Edema

Interventions

DEVICE

Intraosseous

Intraosseous administration of hypertonic saline

DRUG

Hypertonic saline

Intraosseous administration of hypertonic saline

Sponsors & Collaborators

  • Ohio State University

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-21
Primary Completion
2018-04-21
Completion
2018-04-21
FDA Drug
Yes
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03276494 on ClinicalTrials.gov